These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31939837)

  • 1. Negative Trials, and What to Do with Them?: First, Stop Calling Them "Negative".
    Sessler DI
    Anesthesiology; 2020 Feb; 132(2):221-224. PubMed ID: 31939837
    [No Abstract]   [Full Text] [Related]  

  • 2. Negative outcomes in critical care trials: applying the wrong statistics - or asking the wrong questions?
    Charlesworth M; Pandit JJ
    Anaesthesia; 2020 Oct; 75(10):1284-1288. PubMed ID: 32259278
    [No Abstract]   [Full Text] [Related]  

  • 3. Do not hesitate and publish negative results and look for long-term results!
    Faschinger C
    Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2697-2698. PubMed ID: 31515629
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of data display formats on decisions to stop clinical trials. Paper is misleading, like a sheep dressed in a wolf's clothing.
    Walker JM
    BMJ; 1999 Oct; 319(7216):1070. PubMed ID: 10521214
    [No Abstract]   [Full Text] [Related]  

  • 5. When to stop a clinical trial.
    Pocock SJ
    BMJ; 1992 Jul; 305(6847):235-40. PubMed ID: 1392832
    [No Abstract]   [Full Text] [Related]  

  • 6. [Statistical considerations in clinical trials with particular reference to phase III studies].
    Talamini R
    Tumori; 1999; 85(3 Suppl 1):S53-4. PubMed ID: 10542890
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcome reporting bias in clinical trials.
    Esposito E; Cipriani A; Barbui C
    Epidemiol Psichiatr Soc; 2009; 18(1):17-8. PubMed ID: 19378694
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sample size and power analyses in clinical trials].
    Pripp AH
    Tidsskr Nor Laegeforen; 2017 Sep; 137(17):. PubMed ID: 28925211
    [No Abstract]   [Full Text] [Related]  

  • 9. Are large trials less reliable than small trials?
    Rücker G; Schwarzer G; Schumacher M; Carpenter J
    J Clin Epidemiol; 2009 Aug; 62(8):886-7; author reply 887-9. PubMed ID: 19481419
    [No Abstract]   [Full Text] [Related]  

  • 10. Antidepressant Trials: Are the Diminishing Effect Sizes of Efficacy Trials Avoidable?
    Rickels K; Robinson DS
    J Clin Psychopharmacol; 2017 Dec; 37(6):648-650. PubMed ID: 29045306
    [No Abstract]   [Full Text] [Related]  

  • 11. Two-tailed tests and a statistical significance at 0.05: what do they mean?
    Campbell M
    Midwifery; 2004 Jun; 20(2):142-3. PubMed ID: 15177857
    [No Abstract]   [Full Text] [Related]  

  • 12. Study design: statistical and methodologic considerations.
    Rubenfeld GD
    Respir Care; 1995 Sep; 40(9):980-6. PubMed ID: 10152244
    [No Abstract]   [Full Text] [Related]  

  • 13. Statistical reductionism and clinicians' delinquencies in humanistic research.
    Feinstein AR
    Clin Pharmacol Ther; 1999 Sep; 66(3):211-7. PubMed ID: 10511055
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings of the University of Pennsylvania annual conference on statistical issues in clinical trials: emerging statistical issues in the conduct and monitoring of clinical trials.
    Ellenberg JH; Ellenberg SS
    Clin Trials; 2012 Dec; 9(6):669-70. PubMed ID: 23250941
    [No Abstract]   [Full Text] [Related]  

  • 15. Addressing missing data in clinical trials.
    van der Laan M; Lorenz TJ
    Ann Intern Med; 2011 Jul; 155(2):135. PubMed ID: 21768593
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and data monitoring committees for clinical trials.
    Conti CR
    Clin Cardiol; 1995 Aug; 18(8):432. PubMed ID: 7586759
    [No Abstract]   [Full Text] [Related]  

  • 17. When should data and safety monitoring committees share interim results in cardiovascular trials?
    Borer JS; Gordon DJ; Geller NL
    JAMA; 2008 Apr; 299(14):1710-2. PubMed ID: 18398083
    [No Abstract]   [Full Text] [Related]  

  • 18. [How to improve the quality of clinical trials].
    Galende I; Sacristán JA; Soto J
    Med Clin (Barc); 1994 Apr; 102(12):465-70. PubMed ID: 8207997
    [No Abstract]   [Full Text] [Related]  

  • 19. SOP 09: Statistical design and analysis.
    Onkologie; 2003 Oct; 26 Suppl 6():43-7. PubMed ID: 23570186
    [No Abstract]   [Full Text] [Related]  

  • 20. Number needed to harm.
    Safer DJ; Zito JM
    J Nerv Ment Dis; 2013 Nov; 201(11):1003. PubMed ID: 24177491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.